HopeStage
Back to all studies
CompletedNCT07017478

Mood Effects of Serotonin Agonists: Depression

This study assessed sleep quality.

Medication studyAges 18–40United States
The study in practice

Understand this study

What did researchers investigate?

This study assessed sleep quality.

Who was this study for?

Listed age limits: 18 years to 40 years.

Listed locations
ChicagoSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: June 9, 2025
Recruitment status
Completed
Enrollment listed in the registry
41
Sponsor
University of Chicago
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
From 18 Years to 40 Years
Official registry ID
NCT07017478
Official title
Show the full official title

Mood Effects of Serotonin Agonists: Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Chicago

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

This study assessed sleep quality.

Who is behind this study?

The study sponsor is University of Chicago, a university.

Did this study involve medication?

Yes. The study involved medication, including LSD and Placebo.

Who was this study for?

Listed age limits: 18 years to 40 years.

Want to explore more studies?

Explore studies